RT Journal Article
SR Electronic
T1 The bladder microbiome of chronic kidney disease with associations to demographics, renal function, and serum cytokines
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.05.23289568
DO 10.1101/2023.05.05.23289568
A1 Liu, Fengping
A1 Du, Jingjie
A1 Lin, Hao
A1 Xu, Zhenyi
A1 Sun, Yifan
A1 Yan, Feng
A1 Gu, Yifeng
A1 Wang, Yang
A1 Guo, Wei
A1 Zhai, Qixiao
A1 Hu, Jialin
A1 Tian, Yu
A1 Hu, Lei
A1 Jiang, Peng
A1 Wei, Shichao
A1 Gu, Chaoqun
A1 Sheng, Jiayi
A1 Chen, Wei
A1 Wolfe, Alan J.
A1 Feng, Ninghan
YR 2023
UL http://medrxiv.org/content/early/2023/05/05/2023.05.05.23289568.abstract
AB Background High throughput 16S rRNA gene sequencing and enhanced culture methods (e.g., expanded quantitative urine culture, EQUC) have established the existence of the human bladder microbiome. We aim to test the hypothesis that the bladder environment of patients with chronic kidney disease (CKD) differs from that of unaffected controls with associated consequences for the composition of the bladder microbiome.Methods and Materials Females (n=66) and males (n=66) diagnosed with CKD and age-BMI-matched healthy control (HC) females (n=22) and males (n=22) were recruited. Transurethral catheterized urine was collected for 16S rRNA gene sequencing and Expanded Quantitative Urine Culture (EQUC). Fecal samples also were sequenced. Urinary analysis, kidney function and serum cytokines were examined.Results Bladder microbiomes of CKD females and males versus HC females and males differed (FDR<0.05); however, the difference was more obvious in females. In CKD females, sequencing revealed depletion of 5 genera, including Lactobacillus, and enrichment of 14 genera, including Escherichia/Shigella, Bifidobacterium, and several clostridial genera (FDR<0.05), while EQUC detected increased Escherichia and decreased Lactobacillus CKDB(P<0.05). Escherichia-Shigella was positively, whereas Lactobacillus was negatively, associated with CKDB-female serum creatinine (r=0.285, P=0.020; r=-0.337, P=0.006, respectively). Lactobacillus was positively associated with eGFR (r=0.251, P=0.042). Some CKD-related serum cytokines were negatively associated with clostridial genera. In contrast, the fecal microbiomes of CKD and HC females and males did not significantly differ in bacterial diversity or composition. However, bladder and fecal microbiomes of CKD females resembled each other more than those of controls, as assessed by the Bray-Curtis Dissimilarity Index (FDR<0.05).Conclusions CKD bladder microbiomes were dysbiotic, which was more obvious in females. This dysbiosis was associated with kidney damage severity and dysregulation of serum cytokines. The increased similarity between bladder and fecal microbiomes of CKD females suggests possible “gut-leakage.”Competing Interest StatementThe authors have declared no competing interest.Funding StatementWuxi Taihu Talents Program Medical and Health High-level Talents Project (THRCJH20200901); Wuxi key medical discipline construction Municipal Clinical Medical Center (municipal public health center) Project (LCYXZX202103); Wuxi Technological Project (N20192047); Zhejiang Provincial Natural Science Foundation of China (LXR22H160001); National Natural Science Foundation of China (81874142 and 82073041).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of the Affiliated Wuxi Second Hospital of Nanjing Medical University approved the study (Ref. 2018051).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://www.ncbi.nlm.nih.gov/bioproject/PRJNA807874 https://www.ncbi.nlm.nih.gov/bioproject/PRJNA807874